News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
576,684 Results
Type
Article (40415)
Company Profile (78)
Press Release (536191)
Multimedia
Podcasts (46)
Webinars (8)
Section
Business (159963)
Career Advice (2494)
Deals (29856)
Drug Delivery (89)
Drug Development (74786)
Employer Resources (137)
FDA (15988)
Job Trends (12665)
News (288232)
Policy (29047)
Tag
Academia (2308)
Academic (1)
Accelerated approval (6)
Adcomms (22)
Allergies (81)
Alliances (43128)
ALS (92)
Alzheimer's disease (1342)
Antibody-drug conjugate (ADC) (113)
Approvals (15978)
Artificial intelligence (239)
Autoimmune disease (23)
Automation (14)
Bankruptcy (327)
Best Places to Work (10238)
BIOSECURE Act (19)
Biosimilars (99)
Biotechnology (61)
Bladder cancer (74)
Brain cancer (29)
Breast cancer (267)
Cancer (2168)
Cardiovascular disease (156)
Career advice (2083)
Career pathing (28)
CAR-T (149)
Cell therapy (418)
Cervical cancer (19)
Clinical research (61381)
Collaboration (774)
Company closure (1)
Compensation (234)
Complete response letters (24)
COVID-19 (2154)
CRISPR (38)
C-suite (228)
Cystic fibrosis (93)
Data (2112)
Denatured (16)
Depression (51)
Diabetes (247)
Diagnostics (5508)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (33)
Drug discovery (121)
Drug pricing (95)
Drug shortages (24)
Duchenne muscular dystrophy (93)
Earnings (61154)
Editorial (39)
Employer branding (16)
Employer resources (121)
Events (76746)
Executive appointments (691)
FDA (17237)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (696)
Gene editing (96)
Generative AI (22)
Gene therapy (309)
GLP-1 (639)
Government (3697)
Grass and pollen (5)
Guidances (64)
Healthcare (16062)
Huntington's disease (19)
IgA nephropathy (28)
Immunology and inflammation (107)
Indications (28)
Infectious disease (2295)
Inflammatory bowel disease (130)
Inflation Reduction Act (6)
Influenza (47)
Intellectual property (100)
Interviews (480)
IPO (13821)
IRA (34)
Job creations (2830)
Job search strategy (1720)
Kidney cancer (11)
Labor market (25)
Layoffs (360)
Leadership (21)
Legal (6246)
Liver cancer (73)
Lung cancer (313)
Lymphoma (140)
Machine learning (6)
Management (46)
Manufacturing (271)
MASH (59)
Medical device (11194)
Medtech (11198)
Mergers & acquisitions (16535)
Metabolic disorders (625)
Multiple sclerosis (84)
NASH (17)
Neurodegenerative disease (101)
Neuropsychiatric disorders (29)
Neuroscience (1901)
NextGen: Class of 2025 (5514)
Non-profit (4154)
Now hiring (15)
Obesity (326)
Opinion (229)
Ovarian cancer (72)
Pain (89)
Pancreatic cancer (80)
Parkinson's disease (150)
Partnered (21)
Patents (228)
Patient recruitment (113)
Peanut (44)
People (47583)
Pharmaceutical (27)
Pharmacy benefit managers (15)
Phase I (19015)
Phase II (27074)
Phase III (20360)
Pipeline (1159)
Policy (126)
Postmarket research (2180)
Preclinical (7823)
Press Release (46)
Prostate cancer (96)
Psychedelics (31)
Radiopharmaceuticals (230)
Rare diseases (372)
Real estate (4310)
Recruiting (59)
Regulatory (21136)
Reports (29)
Research institute (2070)
Resumes & cover letters (417)
Rett syndrome (5)
RNA editing (5)
RSV (41)
Schizophrenia (79)
Series A (116)
Series B (77)
Service/supplier (3)
Sickle cell disease (50)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (27)
Startups (2905)
State (2)
Stomach cancer (9)
Supply chain (58)
Tariffs (29)
The Weekly (29)
Vaccines (625)
Venture capitalists (33)
Weight loss (209)
Women's health (31)
Worklife (16)
Date
Last 7 days (764)
Last 30 days (2160)
Last 365 days (28992)
2025 (9551)
2024 (31187)
2023 (34989)
2022 (45098)
2021 (48629)
2020 (47061)
2019 (40292)
2018 (30563)
2017 (28373)
2016 (26847)
2015 (31233)
2014 (24090)
2013 (20291)
2012 (21550)
2011 (22284)
2010 (21016)
Location
Africa (720)
Alabama (47)
Alaska (5)
Arizona (142)
Arkansas (12)
Asia (35638)
Australia (5861)
California (5150)
Canada (1869)
China (491)
Colorado (244)
Connecticut (249)
Delaware (124)
Europe (78464)
Florida (822)
Georgia (169)
Idaho (47)
Illinois (484)
India (22)
Indiana (272)
Iowa (8)
Japan (152)
Kansas (95)
Kentucky (20)
Louisiana (11)
Maine (59)
Maryland (741)
Massachusetts (3725)
Michigan (204)
Minnesota (292)
Mississippi (2)
Missouri (77)
Montana (29)
Nebraska (24)
Nevada (59)
New Hampshire (58)
New Jersey (1568)
New Mexico (19)
New York (1563)
North Carolina (830)
North Dakota (9)
Northern California (2238)
Ohio (184)
Oklahoma (13)
Oregon (33)
Pennsylvania (1180)
Puerto Rico (13)
Rhode Island (27)
South America (1017)
South Carolina (22)
South Dakota (1)
Southern California (1997)
Tennessee (89)
Texas (813)
United States (19771)
Utah (159)
Virginia (131)
Washington D.C. (55)
Washington State (489)
West Virginia (2)
Wisconsin (47)
576,684 Results for "society for neuroscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry Approach
April 28, 2025
·
10 min read
Genetown
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
Cerevance will deliver a poster presentation at the upcoming Federation of European Neuroscience Societies (FENS) Forum 2024, taking place in Vienna, Austria, from June 25 – 29, 2024.
June 18, 2024
·
2 min read
BioCapital
Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease
Gain Therapeutics, Inc. today announces the presentation of a poster at the Federation of European Neuroscience Societies (FENS) Forum 2024.
June 27, 2024
·
6 min read
Business
Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials
Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced a partnership with the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe).
June 11, 2024
·
4 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
1 of 57,669
Next
